Hao Peng

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAvionicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 23, 2026
Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.

Hong-Fei Gao, Guo-Lin Ye, Ying Lin

|Mar 21, 2025
Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer.

Yilin Chen, Yuhong Huang, Wei Li

|Aug 23, 2022
N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation.

Hao Peng, Binbin Chen, Wei Wei

|Mar 19, 2022
N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis.

Hui Han, Chunlong Yang, Jieyi Ma

|Feb 26, 2022
N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma.

Binbin Chen, Wei Jiang, Ying Huang

Pageof 1

Frequent Collaborators

3 joint publications

Hui Han

3 joint publications

Chunlong Yang

3 joint publications

Shuibin Lin

1 joint publications

Lirong Wu